These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25613982)
1. Differential pathway coupling of the activated insulin receptor drives signaling selectivity by XMetA, an allosteric partial agonist antibody. Bedinger DH; Goldfine ID; Corbin JA; Roell MK; Adams SH J Pharmacol Exp Ther; 2015 Apr; 353(1):35-43. PubMed ID: 25613982 [TBL] [Abstract][Full Text] [Related]
2. Acute Treatment With XMetA Activates Hepatic Insulin Receptors and Lowers Blood Glucose in Normal Mice. Bedinger DH; Kieffer DA; Goldfine ID; Roell MK; Adams SH J Cell Biochem; 2015 Sep; 116(9):2109-19. PubMed ID: 25808283 [TBL] [Abstract][Full Text] [Related]
3. A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control. Bhaskar V; Goldfine ID; Bedinger DH; Lau A; Kuan HF; Gross LM; Handa M; Maddux BA; Watson SR; Zhu S; Narasimha AJ; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Tran C; Lee SR; Wong S; Wilcock D; White ML; Corbin JA Diabetes; 2012 May; 61(5):1263-71. PubMed ID: 22403294 [TBL] [Abstract][Full Text] [Related]
4. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling. Ahmed Z; Pillay TS Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378 [TBL] [Abstract][Full Text] [Related]
5. Insulin receptor kinase-independent signaling via tyrosine phosphorylation of phosphatase PHLPP1. Zhang M; Riedel H J Cell Biochem; 2009 May; 107(1):65-75. PubMed ID: 19277985 [TBL] [Abstract][Full Text] [Related]
6. Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity. Corbin JA; Bhaskar V; Goldfine ID; Bedinger DH; Lau A; Michelson K; Gross LM; Maddux BA; Kuan HF; Tran C; Lao L; Handa M; Watson SR; Narasimha AJ; Zhu S; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Lee SR; Wong S; Wilcock D; White ML PLoS One; 2014; 9(2):e88684. PubMed ID: 24533136 [TBL] [Abstract][Full Text] [Related]
7. Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B. Giudice J; Leskow FC; Arndt-Jovin DJ; Jovin TM; Jares-Erijman EA J Cell Sci; 2011 Mar; 124(Pt 5):801-11. PubMed ID: 21303927 [TBL] [Abstract][Full Text] [Related]
8. XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesity. Bhaskar V; Lau A; Goldfine ID; Narasimha AJ; Gross LM; Wong S; Cheung B; White ML; Corbin JA Diabetes Obes Metab; 2013 Mar; 15(3):272-5. PubMed ID: 23039274 [TBL] [Abstract][Full Text] [Related]
9. Indinavir and nelfinavir inhibit proximal insulin receptor signaling and salicylate abrogates inhibition: potential role of the NFkappa B pathway. Ismail WI; King JA; Anwar K; Pillay TS J Cell Biochem; 2013 Aug; 114(8):1729-37. PubMed ID: 23386514 [TBL] [Abstract][Full Text] [Related]
10. Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation. Yunn NO; Koh A; Han S; Lim JH; Park S; Lee J; Kim E; Jang SK; Berggren PO; Ryu SH Nucleic Acids Res; 2015 Sep; 43(16):7688-701. PubMed ID: 26245346 [TBL] [Abstract][Full Text] [Related]
11. Insulin regulation of proliferation involves activation of AKT and ERK 1/2 signaling pathways in vascular smooth muscle cells. Isenovic ER; Fretaud M; Koricanac G; Sudar E; Velebit J; Dobutovic B; Marche P Exp Clin Endocrinol Diabetes; 2009 May; 117(5):214-9. PubMed ID: 19235132 [TBL] [Abstract][Full Text] [Related]
12. Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway. Malaguarnera R; Sacco A; Voci C; Pandini G; Vigneri R; Belfiore A Endocrinology; 2012 May; 153(5):2152-63. PubMed ID: 22355074 [TBL] [Abstract][Full Text] [Related]
13. Selective allosteric antibodies to the insulin receptor for the treatment of hyperglycemic and hypoglycemic disorders. Issafras H; Bedinger DH; Corbin JA; Goldfine ID; Bhaskar V; White ML; Rubin P; Scannon PJ J Diabetes Sci Technol; 2014 Jul; 8(4):865-73. PubMed ID: 24876415 [TBL] [Abstract][Full Text] [Related]
14. Continually high insulin levels impair Akt phosphorylation and glucose transport in human myoblasts. Bertacca A; Ciccarone A; Cecchetti P; Vianello B; Laurenza I; Maffei M; Chiellini C; Del Prato S; Benzi L Metabolism; 2005 Dec; 54(12):1687-93. PubMed ID: 16311104 [TBL] [Abstract][Full Text] [Related]
15. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208 [TBL] [Abstract][Full Text] [Related]